Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

NCT00602186 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2008-01-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether Tamsolusin or Prazosin are effective in the treatment of female voiding dysfunction(BOO)

Conditions

  • Neurogenic Bladder

Interventions

DRUG

tamsolusin

0.4 mg /day

DRUG

prazosin

1 mg/day

Sponsors & Collaborators

  • Tabriz University

    lead OTHER

Principal Investigators

  • SAKINEH hajebrahimi, MD · Urology department ofTabriz University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2007-03-31
Completion
2008-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00602186 on ClinicalTrials.gov